Global Sustained-release Medicine Supply, Demand and Key Producers, 2023-2029

Global Sustained-release Medicine Supply, Demand and Key Producers, 2023-2029

The global Sustained-release Medicine market size is expected to reach $ 56060 million by 2029, rising at a market growth of 6.6% CAGR during the forecast period (2023-2029).

The main global manufacturers of sustained-release drugs are Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, etc. The top seven manufacturers occupy a total market share of nearly 35%, of which the largest manufacturer is Sanofi, with a market share of 10.85%. Global sustained-release drug production regions are mainly located in Europe, the United States, China, etc., of which the top two regions occupy more than 65% of the market share. In terms of their product categories, original ground medicine have a higher market share of 63.96%, while generics have a lower share.

Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.

Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (D

This report studies the global Sustained-release Medicine demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Sustained-release Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sustained-release Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Sustained-release Medicine total market, 2018-2029, (USD Million)

Global Sustained-release Medicine total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Sustained-release Medicine total market, key domestic companies and share, (USD Million)

Global Sustained-release Medicine revenue by player and market share 2018-2023, (USD Million)

Global Sustained-release Medicine total market by Type, CAGR, 2018-2029, (USD Million)

Global Sustained-release Medicine total market by Distribution Channel, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Sustained-release Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Novartis, Bayer, Johnson & Johnson, Takeda, AstraZeneca, AbbVie, Pfizer and Collegium Pharmaceutical, Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sustained-release Medicine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Distribution Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Sustained-release Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Sustained-release Medicine Market, Segmentation by Type
Original Ground Medicine
Generic Medicine

Global Sustained-release Medicine Market, Segmentation by Distribution Channel
Hospital
Drugstore
Other

Companies Profiled:
Sanofi
Novartis
Bayer
Johnson & Johnson
Takeda
AstraZeneca
AbbVie
Pfizer
Collegium Pharmaceutical, Inc
Endo Pharmaceuticals
Shanghai Shyndec Pharmaceutical
Zhuhai Rundu Pharmaceutical
China Res Double-Crane

Key Questions Answered

1. How big is the global Sustained-release Medicine market?

2. What is the demand of the global Sustained-release Medicine market?

3. What is the year over year growth of the global Sustained-release Medicine market?

4. What is the total value of the global Sustained-release Medicine market?

5. Who are the major players in the global Sustained-release Medicine market?

6. What are the growth factors driving the market demand?